Melanotan II vs PT-141
Same melanocortin mechanism, opposite regulatory standing: bremelanotide cleared phase 3 for one narrow indication, while Melanotan II never entered that system at all.
Melanotan II
MT-2
Genuinely tans skin via MC1R, but it's an unapproved gray-market injectable with a documented harm record (priapism, changing moles) — and it is not the approved drug afamelanotide.
Full Melanotan II evidence reviewPT-141
Bremelanotide / Vyleesi
FDA-approved as Vyleesi for HSDD in premenopausal women, with phase-3 evidence — but the off-label use in men and at higher doses goes beyond what's proven.
Full PT-141 evidence reviewSide by side
| Melanotan II | PT-141 | |
|---|---|---|
| Marketed for | Tanning, libido | Libido, sexual dysfunction |
| Evidence grade | Clinical data | FDA-approved |
| Family | Sexual / melanocortin | Sexual / melanocortin |
| Regulatory status | Not FDA-approved | FDA-approved |
| How it's obtained | Research-only | Compounded |
| Key human source | Habbema, Int J Dermatol 2017 | RECONNECT phase 3, Obstet Gynecol 2019 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
Bremelanotide is the active metabolite of Melanotan II, which is why they share effects such as nausea, flushing, and pigmentation changes, but the resemblance ends there. PT-141 is FDA-approved as Vyleesi for acquired, generalized HSDD in premenopausal women, with replicated placebo-controlled evidence and a label built around its transient blood-pressure rise. Melanotan II has no approval anywhere, is sold as unregulated injectable powder, and carries a documented harm record: nausea and flushing, blood-pressure and cardiovascular effects, priapism, new and darkening moles that complicate melanoma surveillance, and rare severe events including renal infarction and posterior reversible encephalopathy syndrome. It is also not afamelanotide, the approved melanocortin drug it is often confused with.
Melanotan II fits if
Melanotan II is worth understanding mainly so you can recognize its documented risks and the common false claim that it is basically an approved drug.
PT-141 fits if
PT-141 is the appropriate one to look into only inside its approved indication and under supervision, given the blood-pressure effect.
Where to get it
Where to get peptide therapy
Clinician-led telehealth services that prescribe compounded peptides. The specific peptides offered vary by provider — confirm Melanotan II availability before ordering.
